Pure-play consumer health company Kenvue Inc (NYSE:KVUE) reported first-quarter sales of $3.89 billion, beating the consensus of $3.79 billion. Kenvue’s some of the iconic brands include Aveeno, ...
(Reuters) -Kenvue cut its annual sales forecast on Thursday, as the consumer health company undergoes a strategic review aiming to boost brand performance amid a cautious spending environment. The ...
May 7 (Reuters) - Kenvue (KVUE.N), opens new tab will cut 4% of its global workforce amid investments to grow its key brands, the Tylenol and Band-Aid maker said on Tuesday, as it topped beat Wall ...
Kimberly-Clark, company behind Huggies and Kleenex, acquiring Kenvue, maker of Tylenol, and Band-Aid
Kimberly-Clark, maker of Cottonelle and Scott toilet paper, Huggies and Kleenex tissues is buying Kenvue. The purchase adds Listerine mouthwash, Band-Aid, Neutrogena, Aveeno, Benadryl, and Zyrtec to ...
Feb 8 (Reuters) - Kenvue (KVUE.N), opens new tab forecast full-year profit below analysts' expectations after missing quarterly sales estimates on Thursday, as the Tylenol maker faces sluggish demand ...
NEW YORK (Reuters) -Billionaire investor Daniel Loeb's hedge fund Third Point is building a stake in Kenvue, sources familiar with the matter said on Friday, as some investors are pushing for ...
Kenvue targets annualized pre-tax gross cost savings of around $350 million by 2026 after workforce reduction of 4%. Kenvue expects the full year 2024 reported net ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results